Health News

Does Your Blood Type Indicate Stroke Risk?
Some individuals may be at a higher risk of stroke simply by nature of their blood type. Those with blood type AB may be at an increased risk of stroke regardless of other factors.
Gout Drug May Love Your Heart
Patients that develop a common heart arrhythmia may benefit from an unexpected drug. A medication used to treat gout appears to reduce the incidence of atrial fibrillation following heart surgery.
Don't Catch a Cold After Heart Surgery
Prior to heart surgery, many patients are concerned that there could be complications such as infection from the deep incision. Pneumonia is actually the most common serious infection after a cardiac operation.
Injecting Your Way to Lower Cholesterol
Lowering your cholesterol could be as easy as a shot. Preliminary clinical tests have shown that injections may work to lower "bad" LDL cholesterol.
Experimental Cholesterol Drug Shows Promise
Eli Lily's experimental drug evacetrapib has been shown to raise good cholesterol levels while also decreasing bad cholesterol. It also successfully lowered triglyceride levels.
Reverse Artery Plaque With Medications
Large doses of common cholesterol-lowering medications appear to reverse coronary artery disease by reducing the amount of plaque in clogged arteries.
Heart Surgeon Not Required for Elective Angioplasty
As long as patients seek elective angioplasty and stent placement to open clogged arteries at an experienced hospital, it may not matter whether the medical facility maintains onsite heart surgeons.
Stem Cells Reverse Heart Failure Damage
Preliminary clinical trial results suggest that adult stem cells may be able to reverse moderate to severe congestive heart failure.
Abnormal Heart Rhythm Drug Increases Risk of Dying
A drug that aids patients with intermittent atrial fibrillation, a common heart arrhythmia, increased the risk of death among patients with permanent atrial fibrillation. As a result the study was halted early.
Apixaban Fails to Reduce Blood Clots
An experimental drug designed to aid severely ill patients after hospitalization is not more effective than standard treatments for reducing the risk of blood clots, a study has confirmed.